Interferon-beta (IFN-β) is a polypeptide drug that reduces neuronal inflammation and is approved for the treatment of relapsing-remitting multiple sclerosis (MS) while IFN-α has been used for the treatment of chronic hepatitis C (53–55). Here, IFNB1 is linked to relapsing-remitting multiple sclerosis.